Analyst Information
Matt O'BrienSr. Research Analyst Matt O'Brien is a senior research analyst and managing director at Piper Sandler covering medical technology and devices. Before joining Piper in 2014, O'Brien covered medical technology at William Blair for 10 years. Additional work experience includes five years of middle-market investment banking financial advisory work and two years at a healthcare manufacturing and distribution company. O'Brien holds an MBA from the University of Chicago Booth School of Management and a BS in Finance from DePaul University. |
|
Universe Coverage: Healthcare: Medical Technology and Devices | |
| ABMD | ABIOMED, Inc. |
| ATEC | Alphatec Holdings, Inc. |
| APYX | Apyx Medical Corporation |
| ATRC | AtriCure, Inc. |
| AZYO | Aziyo Biologics, Inc. |
| BAX | Baxter International Inc. |
| BSX | Boston Scientific Corporation |
| CNMD | CONMED Corporation |
| COO | Cooper Companies, Inc. (The) |
| CUTR | Cutera, Inc. |
| DXCM | DexCom, Inc. |
| GKOS | Glaukos Corporation |
| GMED | Globus Medical, Inc. |
| PODD | Insulet Corporation |
| IART | Integra LifeSciences Holdings Corporation |
| ITMR | Itamar Medical Ltd. |
| MDT | Medtronic plc |
| MMSI | Merit Medical Systems, Inc. |
| MOTS | Motus GI Holdings, Inc. |
| STIM | Neuronetics, Inc. |
| NUVA | NuVasive, Inc. |
| KIDS | OrthoPediatrics Corp. |
| KRMD | Repro-Med Systems, Inc. |
| SPNE | SeaSpine Holdings Corporation |
| SYK | Stryker Corporation |
| TCMD | Tactile Systems Technology, Inc. |
| TNDM | Tandem Diabetes Care, Inc. |
| TELA | TELA Bio, Inc. |
| TFX | Teleflex Incorporated |
| ZBH | Zimmer Biomet Holdings, Inc. |
| ZYXI | Zynex, Inc. |
